H. Edward Fleming's Insider Trades & SAST Disclosures

H. Edward Fleming's most recent trade in Sionna Therapeutics Inc. was a trade of 17,340 Non-Qualified Stock Option (right to buy) done . Disclosure was reported to the exchange on June 17, 2026.

Share

Note

This is a custom search result for pattern H. Edward Fleming.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Sionna Therapeutics Inc	H. Edward Fleming	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jun 2026	17,340	17,340	-		-	Non-Qualified Stock Option (right to buy)
Upstream Bio Inc	H. Edward Fleming	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jun 2026	17,096	17,096	-		-	Stock Option (Right to Buy)
CRISPR Therapeutics AG	H. Edward Fleming	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2026	13,000	13,000	-		-	Stock Option (Right to Buy)
Sionna Therapeutics Inc	H. Edward Fleming	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2025	19,959	19,959	-		-	Non-Qualified Stock Option (right to buy)
Upstream Bio Inc	H. Edward Fleming	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jun 2025	17,096	17,096	-		-	Stock Option (Right to Buy)
CRISPR Therapeutics AG	H. Edward Fleming	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2025	13,000	13,000	-		-	Stock Option (Right to Buy)
Upstream Bio Inc	Fleming H. Edward	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Oct 2024	17,096	17,096	-		-	Stock Option (Right to Buy)
CRISPR Therapeutics AG	H. Edward Fleming	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 May 2024	13,000	13,000	-		-	Stock Option (Right to Buy)
CRISPR Therapeutics AG	H Edward Fleming	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jun 2022	12,000	12,000	-		-	Stock Option (Right to Buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades